Solventum Corporation (SOLV) Earnings Call Analysis

NYSE · Healthcare · Health Information Services

20/25

Growth 5 Margin 4 Expansion 5 Platform 2 Financial 4

latest quarter score

Earnings Reports

20
Solventum (SOLV) Q2 2026: HIS Separation Unlocks Pure-Play Med Tech Focus, 9.5% Organic Growth Drives Guidance Raise
August 06, 2026
22
Solventum (SOLV) Q1 2026: $100M ERP Order Shift Sets Up Margin Expansion and Portfolio Flexibility
May 06, 2026
16
Solventum (SOLV) Q4 2025: $1B Buyback Launch Signals Capital Flexibility as Margin Expansion Targets Hold
February 27, 2026
15
Solventum (SOLV) Q3 2025: 2.5% Underlying Growth Reveals Volume-Led Recovery Across Four Segments
November 07, 2025
22
Solventum (SOLV) Q2 2025: EPS Guidance Raised by $0.32 as Margin Levers Offset Separation Costs
August 08, 2025
14
Solventum (SOLV) Q1 2025: Tariff Headwinds Tighten as $80M–$100M Impact Hits H2 Margins
July 05, 2025
Solventum (SOLV) Q4 2024: 2.3% Organic Sales Growth Signals Early Turnaround Amid Complex Spin-Off
February 27, 2025

Browse all companies